News and press releases
Stay up to date with the Association’s news and events.
![](https://cdn.prod.website-files.com/638f893112c6eac0e46ac576/63c809b0acaf27b0a4de4c33_resources-hero_cell1.webp)
![](https://cdn.prod.website-files.com/638f893112c6eac0e46ac576/63c809af6100c642491b1144_resources-hero_cell2.webp)
![](https://cdn.prod.website-files.com/638f893112c6eac0e46ac576/63c809b0c9a071f3e1315c44_resources-hero_cell3.webp)
![](https://cdn.prod.website-files.com/638f893112c6eac0e46ac576/63c809aff7e7c55068ea25b5_resources-hero_cell4.webp)
![](https://cdn.prod.website-files.com/638f893112c6eac0e46ac576/63c809b0c077d95e001f56d8_resources-hero_cell5.webp)
![](https://cdn.prod.website-files.com/638f893112c6eac0e46ac576/63c809b0a95ec247802ff9ad_resources-hero_cell6.webp)
Quick links
Press releases
PPTA statements
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Jun 27, 2022
Monkeypox Virus and Plasma Protein Therapies
PPTA considers that the current MPXV outbreak is not a concern for the safety margins of plasma protein therapies manufactured by PPTA member companies. This assessment is also shared by other concerned parties (AABB, WHO).
All
PPTA statements
Jun 27, 2022
Monkeypox Virus and Plasma Protein Therapies
PPTA considers that the current MPXV outbreak is not a concern for the safety margins of plasma protein therapies manufactured by PPTA member companies. This assessment is also shared by other concerned parties (AABB, WHO).
All
PPTA statements
Mar 17, 2022
PPTA Statement on the Ukraine Crisis
The Plasma Protein Therapeutics Association (PPTA) expresses serious concern about the ongoing hostilities in Ukraine and the devastating impact on the lives of people in the region.
All
PPTA statements
Mar 17, 2022
PPTA Statement on the Ukraine Crisis
The Plasma Protein Therapeutics Association (PPTA) expresses serious concern about the ongoing hostilities in Ukraine and the devastating impact on the lives of people in the region.
All
PPTA statements
Feb 18, 2022
PPTA Leadership Update – Amy Efantis
Dear PPTA Members and Patient Stakeholders, We are writing to you today to inform you that Amy Efantis, PPTA’s president & CEO, recently informed the Global Board of Directors of her decision to leave the association.
All
PPTA statements
Feb 18, 2022
PPTA Leadership Update – Amy Efantis
Dear PPTA Members and Patient Stakeholders, We are writing to you today to inform you that Amy Efantis, PPTA’s president & CEO, recently informed the Global Board of Directors of her decision to leave the association.
All
PPTA statements
Feb 16, 2022
PPTA Disagrees with Ruling from Romanian Competition Council
The Plasma Protein Therapeutics Association (PPTA) disagrees with the 15 February 2022 ruling from the Romanian Competition Council (RCC) finding that PPTA directed manufacturers to withhold immunoglobulin (Ig) therapies from the Romanian market to force repeal of the so-called “clawback” tax.
All
PPTA statements
Feb 16, 2022
PPTA Disagrees with Ruling from Romanian Competition Council
The Plasma Protein Therapeutics Association (PPTA) disagrees with the 15 February 2022 ruling from the Romanian Competition Council (RCC) finding that PPTA directed manufacturers to withhold immunoglobulin (Ig) therapies from the Romanian market to force repeal of the so-called “clawback” tax.
All
PPTA statements
No results found